Anthem Biosciences IPO Details: Anthem Biosciences Limited is set to launch its Initial Public Offering (IPO) on July 14, 2025, with the issue closing on July 16, 2025. The IPO is a Book-Building Issue, aiming to raise approximately ₹3,395 crores, comprising a fresh issue of ₹[.] crores and an offer for sale of up to 5,95,61,404 equity shares with a face value of ₹2 each.
The price band for the Anthem Biosciences IPO is fixed at ₹540 to ₹570 per equity share. The allocation is structured as follows: 50% for Qualified Institutional Buyers (QIBs), 15% for Non-Institutional Investors (HNIs), and 35% for Retail Investors. The shares are proposed to be listed on both BSE and NSE, with the expected listing date on July 21, 2025. The basis of allotment is scheduled for July 17, 2025.
In terms of financial performance, the company reported a revenue of ₹1,930.29 crores in FY2025, up from ₹1,483.07 crores in FY2024. The net profit stood at ₹451.26 crores in FY2025, compared to ₹367.31 crores in FY2024. Based on its robust financial growth, the IPO appears to be a promising opportunity for long-term investors.
Anthem Biosciences IPO Objectives:
The Company will not receive any proceeds from the Offer (the “Offer Proceeds”) and all the Offer Proceeds will be received by the Selling Shareholders after deduction of Offer related expenses and relevant taxes thereon, to be borne by the respective Selling Shareholders.
Anthem Biosciences IPO Review (Apply or Not)
- Apply
Anthem Biosciences IPO Date & Price Band Details:
| IPO Open Date: | July 14, 2025 |
| IPO Close Date: | July 16, 2025 |
| Face Value: | ₹2 Per Equity Share |
| IPO Price Band: | ₹540 to ₹570 Per Share |
| Issue Size: | Approx ₹3,395 Crores |
| Offer for Sale: | Approx 5,95,61,404 Equity Shares |
| Issue Type: | Book Build Issue |
| IPO Listing: | BSE & NSE |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Anthem Biosciences IPO Lot Size:
The minimum lot size for the Anthem Biosciences IPO is 26 equity shares, requiring an application amount of ₹14,820. Retail investors are permitted to apply for up to 13 lots, equivalent to 338 shares, for a maximum investment of ₹1,92,660.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 26 | ₹14,820 |
| Retail Maximum | 13 | 338 | ₹1,92,660 |
| S-HNI Minimum | 14 | 364 | ₹2,07,480 |
| B-HNI Minimum | 68 | 1,768 | ₹10,07,760 |
Anthem Biosciences IPO Allotment & Listing Date (Details)
The Anthem Biosciences IPO will open on July 14, 2025, and close on July 16, 2025. The basis of allotment is expected to be finalized on July 17, 2025, with the company’s shares scheduled to be listed on BSE and NSE on July 21, 2025.
| IPO Open Date: | July 14, 2025 |
| IPO Close Date: | July 16, 2025 |
| Basis of Allotment: | July 17, 2025 |
| Refunds: | July 18, 2025 |
| Credit to Demat Account: | July 18, 2025 |
| IPO Listing Date: | July 21, 2025 |
Anthem Biosciences IPO GMP Today:
the latest Grey Market Premium (GMP) for the Anthem Biosciences IPO stands at ₹148. Based on the upper price band of ₹570 per share, the estimated listing price is projected to be around ₹718, indicating a potential listing gain of approximately 25.96% per share.
Promoters of Anthem Biosciences IPO
The promoters of the company are Ajay Bhardwaj, Ganesh Sambasivam, K Ravindra Chandrappa and Ishaan Bhardwaj.
About Anthem Biosciences IPO
Anthem Biosciences Limited, founded in 2006, is one of the growing innovation-driven and technology-focused Contract Research, Development and Manufacturing Organizations (“CRDMO”) with end-to-end operations covering drug discovery, development, and manufacturing. Anthem Biosciences is one of the few companies in India with integrated capabilities in New Chemical Entities (NCE) and New Biological Entities (NBE) throughout drug discovery, development, and commercial manufacturing.
Anthem Biosciences is a one-stop service provider engaged in serving a wide range of customers, including emerging biotech companies and large pharmaceutical firms around the world. The company is involved in the manufacturing of specialized fermentation-based APIs, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars. The company has supplied to over 150 customers, from small biotech to large pharmaceutical companies, as of March 31, 2024. Currently, the company has a team of 600 employees, including medicinal chemists, microbiologists, molecular biologists, biochemists, and chemical engineers.
Anthem Biosciences IPO Company Financial Report
The company reported revenue of ₹1,930.29 crores in 2025 against ₹1,483.07 crore in 2024. The company reported profit of ₹451.26 crores in 2025 against profit of ₹367.31 crores in 2024.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2022 | ₹1,280.24 | ₹734.10 | ₹405.54 | ₹1,618.87 |
| 2023 | ₹1,133.99 | ₹698.50 | ₹385.19 | ₹2,014.46 |
| 2024 | ₹1,483.07 | ₹1,005.75 | ₹367.31 | ₹2,398.11 |
| 2025 | ₹1,930.29 | ₹1,273.42 | ₹451.26 | ₹2,807.58 |
Anthem Biosciences IPO Valuation – FY2025
Check Anthem Biosciences IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 20.82% |
| ROCE: | 27.64% |
| EBITDA Margin: | 36.81% |
| PAT Margin: | 23.38% |
| Debt to equity ratio: | 0.05 |
| Earning Per Share (EPS): | ₹8.07 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 20.82% |
| Net Asset Value (NAV): | ₹43.10 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Syngene International Limited | 12.35 | 51.54 | 11.05% | 117.42 | 3,642.40 Cr. |
| Sai Life Sciences Limited | 8.83 | 92.18 | 10.96% | 102.12 | 1,694.57 Cr. |
| Suven Life Sciences Limited | 10.52 | 97.29 | 13.61% | 72.31 | 1,197.58 Cr. |
| Divi’s Laboratories Limited | 82.53 | 83.22 | 15.35% | 564.87 | 9,360.00 Cr. |
Anthem Biosciences IPO Registrar
KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: anthem.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
IPO Lead Managers aka Merchant Bankers
- Jm Financial Limited
- Citigroup Global Markets India Private Limited
- J.P. Morgan India Private Limited
- Nomura Financial Advisory And Securities (India) Pvt Ltd
Company Address
Anthem Biosciences Limited
No. 49, F1 & F2, Canara Bank Road
Bommasandra Industrial Area, Phase 1,
Bommasandra,
Bengaluru, Karnataka, 560099
Phone: +91 080 6672 400
Email: investors.abl@anthembio.com
Website: https://www.anthembio.com/
Anthem Biosciences IPO – Frequently Asked Questions (FAQs)
1. What is the Anthem Biosciences IPO?
Anthem Biosciences IPO is a Mainboard Initial Public Offering through which the company aims to raise approximately ₹3,395 crores. The price band for the issue is ₹540 to ₹570 per equity share, and the IPO will be listed on both BSE and NSE.
2. When will the Anthem Biosciences IPO open for subscription?
The IPO will open for subscription on July 14, 2025, and will close on July 16, 2025, for all categories including Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Investors.
3. What is the investors’ quota in the Anthem Biosciences IPO?
The IPO allocation is divided as follows:
- 50% for QIBs
- 15% for NIIs (HNIs)
- 35% for Retail Investors
4. How can investors apply for the Anthem Biosciences IPO?
Investors can apply through the ASBA facility available via their bank accounts. Applications can also be submitted online using UPI through stockbrokers or by submitting a physical application form through registered brokers.
5. What is the total issue size of the Anthem Biosciences IPO?
The total issue size is approximately ₹3,395 crores.
6. What is the price band for the Anthem Biosciences IPO?
The IPO price band is fixed between ₹540 and ₹570 per equity share.
7. What is the lot size for the Anthem Biosciences IPO?
The minimum application size is 26 shares, requiring an investment of ₹14,820.
8. When will the Anthem Biosciences IPO allotment be finalized?
The basis of allotment is expected to be finalized on July 17, 2025.
9. What is the listing date for the Anthem Biosciences IPO?
The shares of Anthem Biosciences are scheduled to be listed on July 21, 2025, on BSE and NSE.
